Reusable medical device testing | Materials Metric
Reusable medical device testing must account for cumulative exposure. Materials Metric explains how reprocessing changes biocompatibility needs.
READ MOREMaterials Metric Blog | Expert Insights
Reusable medical device testing must account for cumulative exposure. Materials Metric explains how reprocessing changes biocompatibility needs.
READ MOREUsing ISO 10993 existing data wisely can reduce new testing. Materials Metric explains when prior data is acceptable and when…
READ MOREAvoid the most common FDA biocompatibility deficiencies before they delay your submission. Materials Metric breaks down what triggers them.
READ MOREDeformulation analysis breaks a product down into its ingredients and ratios. Materials Metric explains how reverse engineering reveals a formulation.
READ MOREProving device material equivalency can save costly retesting. Materials Metric explains how to build a justification FDA will accept.
READ MORERisk-based biocompatibility testing focuses effort where it matters most. Materials Metric shows how to scope a defensible, efficient program.
READ MOREISO 10993-18 governs chemical characterization of medical devices. Materials Metric explains what the standard requires and how to apply it.
READ MOREHow the analytical evaluation threshold is calculated and why it matters for E&L studies. Materials Metric explains AET in plain…
READ MOREA toxicological risk assessment turns chemistry data into safety conclusions. Materials Metric explains how a TRA supports device biocompatibility.
READ MOREUnderstand how the FDA chemical characterization review works before you submit. Materials Metric explains what reviewers look for in E&L…
READ MORE